We are a private owned company based in Milan, Italy, founded in 2019. We have proudly developed and manufactured a unique, innovative medical device to facilitate and support the Interventional Cardiologist during Valve in Valve procedures in conjunction with a Transcatheter Aortic Valve implantation.

The treatment of aortic valve desease in the developed countries is dominated by the Transcatheter Aortic Valve Replacement (TAVR), representing today a 5Bin US$ market worldwide.

An important portion of this huge and growing market is represented by Valve in Valve procedures.

Crossing a degenerated prosthetic valve is a big and unmet challenge today by any operator, with high risks of patient complications, long procedural time and X-ray exposure.

We have a solution to address the challenges, improve safety and procedural outcome of any Valve in Valve procedure.